The M. tuberculosis Ag85A is being tested as TB vaccine candidate, delivered by MVA vector (MVA85A) and has been shown to induce CD4+ and CD8+ T cell responses and when used to boost BCG-vaccinated adult or infant humans [23]. This evidence concerns the gene CD4 and tuberculosis.